Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 11/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17529717 | 1.00 | TSHR (0.39) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL29210045 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL21052095 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL17529754 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL17529869 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL14840450 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL29210039 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL1324014 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL14840397 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL14840250 | 0.97 | TSHR (0.44) | TSHRTHRBFDPSGGPS1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11279790-B2 | Process for producing polyisocyanurate plastics by means of phosphine catalysis | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-22 | — | — | US | claimed |
| EP-3507321-B1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-03-02 | — | — | EP | claimed |
| EP-3507321-A1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | Covestro Deutschland AG (DE) | 2019-07-10 | — | — | EP | claimed |
| US-20190202963-A1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO DEUTSCHLAND AG (DE) | 2019-07-04 | — | — | US | claimed |
| WO-2018041800-A1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO DEUTSCHLAND AG (DE) | 2018-03-08 | — | — | WO | claimed |
| US-12492281-B2 | Polyisocyanurate materials as electrical potting compounds | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-09 | — | — | US | disclosed |
| WO-2024098840-A1 | ISOBUTYLENE-BASED CATIONIC SALT POLYMER, PREPARATION METHOD THEREFOR, USE THEREOF, AND ANTIBACTERIAL POLYMER MATERIAL | 中国石油化工股份有限公司 | 2024-05-16 | — | — | WO | disclosed |
| US-11319402-B2 | Method for producing a polyisocyanate polymer and a polyisocyanurate plastic | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2022-05-03 | — | — | US | disclosed |
| US-20220127407-A1 | POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS | COVESTRO DEUTSCHLAND AG (DE) | 2022-04-28 | — | — | US | disclosed |
| US-11279790-B2 | Process for producing polyisocyanurate plastics by means of phosphine catalysis | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-22 | — | — | US | disclosed |
| EP-3507321-B1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-03-02 | — | — | EP | disclosed |
| US-20210246255-A1 | METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2021-08-12 | — | — | US | disclosed |
| WO-2014168762-A1 | ANTIMICROBIAL CATIONIC POLYCARBONATES | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-10-16 | — | — | WO | disclosed |
| WO-2014168771-A2 | ANTIMICROBIAL CATIONIC POLYCARBONATES | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-10-16 | — | — | WO | disclosed |
| WO-2014168772-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-10-16 | — | — | WO | disclosed |
| US-20140301967-A1 | ANTIMICROBIAL CATIONIC POLYCARBONATES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-10-09 | — | — | US | disclosed |
| US-20140301970-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-10-09 | — | — | US | disclosed |
| US-20140301968-A1 | ANTIMICROBIAL CATIONIC POLYCARBONATES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-10-09 | — | — | US | disclosed |
| US-8058382-B2 | Uretdione formation in solution | BAYER MATERIALSCIENCE AG (DE) | 2011-11-15 | — | — | US | disclosed |
| US-20060173152-A1 | Uretdione formation in solution | BAYER MATERIALSCIENCE AG | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140301967-A1 | ANTIMICROBIAL CATIONIC POLYCARBONATES | VDR, GC, CYP24A1 | TSHR 4067/4885THRB 3810/4885FDPS 1842/4885 |
| US-20140301968-A1 | ANTIMICROBIAL CATIONIC POLYCARBONATES | VDR, GC, CYP24A1 | TSHR 4067/4885THRB 3810/4885FDPS 1842/4885 |
| US-20140301970-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | VDR, PROC, CYP24A1 | TSHR 4511/4885THRB 2554/4885FDPS 2484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.